Page last updated: 2024-10-16

carnitine and Diffuse Myofascial Pain Syndrome

carnitine has been researched along with Diffuse Myofascial Pain Syndrome in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Fibromyalgia is a clinically defined chronic condition of unknown etiology characterized by chronic widespread pain that often co-exists with sleep disturbances, cognitive dysfunction and fatigue."2.58Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. ( Häuser, W; Klose, P; Üçeyler, N; Walitt, B; Welsch, P, 2018)
"Many patients with chronic fatigue syndrome(CFS) fulfill the criteria of FMS and represent one end of a spectrum of presentation."2.40[Fibromyalgia syndrome]. ( Matsumoto, Y, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Welsch, P1
Üçeyler, N1
Klose, P1
Walitt, B1
Häuser, W1
Matsumoto, Y1

Reviews

2 reviews available for carnitine and Diffuse Myofascial Pain Syndrome

ArticleYear
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    The Cochrane database of systematic reviews, 2018, 02-28, Volume: 2

    Topics: Adrenergic Uptake Inhibitors; Adult; Carnitine; Cyclopropanes; Desvenlafaxine Succinate; Duloxetine

2018
[Fibromyalgia syndrome].
    Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57, Issue:2

    Topics: Biomarkers; Carnitine; Diagnosis, Differential; Fatigue; Fatigue Syndrome, Chronic; Fibromyalgia; Hu

1999